INC Research, Inc. Appoints Christopher Gaenzle as General Counsel

Raleigh, NC, April 10, 2012 - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced Christopher L. Gaenzle has joined the Company as its general counsel. Gaenzle will be part of INC Research’s executive team and will report to Chief Executive Officer James Ogle. As general counsel, Gaenzle will be responsible for the Company’s overall global legal strategy, including contract negotiations, regulatory issues, strategic acquisitions, customer projects and intellectual property matters. He will provide global leadership for INC Research’s legal resources, including management of the Company’s in-house legal department and outside counsel relationships.

“We are extremely pleased to have Chris join INC Research,” said Chief Executive Officer James Ogle. “Chris brings a wealth of experience and a solid understanding of the regulatory and legal issues affecting the Company and the pharmaceutical industry, and will be a valuable addition to our executive team.”

Prior to joining INC Research, Gaenzle was assistant general counsel at Pfizer Inc. His experience also includes serving as a partner at Hunton and Williams.

Gaenzle received his undergraduate degree from Colgate University and earned his JD from Syracuse University. He was also a visiting student at Washington & Lee University School of Law. Gaenzle is admitted to the bar in New York and Virginia.

About INC Research

INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The Company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.